This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.

Why invest in us?

Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.

Latest performance

Share price chart

Reports and presentations

Vectura Group plc interim results for the six months ending 30 September 2014

Annual Report and Accounts for Year Ended 31 March 2014

JP Morgan Healthcare Conference, London

Share price
Upcoming event
03 Dec 2014

Berenberg European Conference, Surrey